Related Experiment Video

Updated: Mar 27, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.5K

DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53

Zhengdong Zhang1, Chun Chen2, Weike Guo3

  • 1Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China (mainland).

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|January 20, 2016
PubMed
Abstract

Insights

Dynamin3 (DNM3) is downregulated in hepatocellular carcinoma. Upregulating DNM3 inhibits cancer cell growth and promotes apoptosis, suggesting DNM3 as a potential therapeutic target for liver cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent malignancy in China with rising mortality.
  • Previous studies indicated reduced Dynamin3 (DNM3) mRNA levels in HCC tissues.
  • The role of DNM3 in HCC pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the expression pattern of DNM3 in HCC.
  • To elucidate the functional role of DNM3 in HCC progression.
  • To explore the therapeutic potential of modulating DNM3 in HCC.

Main Methods:

  • DNM3 expression analysis in HCC tissues and cell lines.
  • In vitro functional assays: proliferation, colony formation, cell cycle, and apoptosis.
  • Correlation analysis of DNM3 expression with clinical parameters.

Main Results:

  • DNM3 expression is significantly downregulated in HCC tissues and correlates with vein invasion and metastasis.
  • Overexpression of DNM3 suppresses HCC cell proliferation and colony formation.
  • DNM3 upregulation induces G0/G1 cell cycle arrest and promotes apoptosis in HCC cells, potentially via p53 pathway activation.

Conclusions:

  • DNM3 exhibits tumor-suppressive properties in HCC by inhibiting proliferation and inducing apoptosis.
  • Modulating DNM3 expression presents a promising therapeutic strategy for HCC treatment.

More Related Videos

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

3.3K
Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K